Medpace Holdings (MEDP) Cash from Investing Activities (2015 - 2026)
Medpace Holdings' (MEDP) quarterly Cash from Investing Activities came in at -$23.9 million in Q2 2026, down 296.76% YoY from $12.1 million in Q2 2025, and down 253.96% on a QoQ basis from -$6.7 million in Q1 2026.
Medpace Holdings (MEDP) Cash from Investing Activities (2015 - 2026) Analysis & Trends
Medpace Holdings (MEDP) has 12 years of Cash from Investing Activities data on file, last reported at -$23.9 million in Q2 2026.
- Quarterly Cash from Investing Activities fell 296.76% year-over-year to -$23.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$45.8 million (down 34.39% YoY) and the FY2025 annual result came in at -$31.1 million, down 10.0% from the prior year.
- Cash from Investing Activities fell to -$23.9 million in Q2 2026, from -$6.7 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $2.5 million in Q1 2024 to a low of -$23.9 million in Q2 2026.
- A 5-year average of -$9.1 million and a median of -$8.9 million in 2022 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2024 — Cash from Investing Activities soared 126.62% — and 2025, when it slumped 494.74%.
- Tracing MEDP's Cash from Investing Activities over 5 years: stood at -$9.2 million in 2022, then rose by 13.26% to -$8.0 million in 2023, then advanced by 5.44% to -$7.6 million in 2024, then surged by 40.85% to -$4.5 million in 2025, then plunged by 433.98% to -$23.9 million in 2026.
- The last three Cash from Investing Activities figures came in at -$23.9 million (Q2 2026), -$6.7 million (Q1 2026), and -$4.5 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 164.00 Mn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -10.15 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | -25.50 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | -77.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -381.00 Mn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -32.14 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -122.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -1.94 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | -134.00 Mn |
| 10 | Medpace Holdings | 16.54 Bn | 16.03 Bn | 201.64 Mn | -23.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -23.89 Mn |
| Jun 30, 2026 | -23.89 Mn |
| Mar 31, 2026 | -6.75 Mn |
| Mar 31, 2026 | -6.75 Mn |
| Dec 31, 2025 | -4.47 Mn |
| Dec 31, 2025 | -4.47 Mn |
| Sep 30, 2025 | -10.66 Mn |
| Sep 30, 2025 | -10.66 Mn |
| Jun 30, 2025 | -6.02 Mn |
| Jun 30, 2025 | -6.02 Mn |
| Mar 31, 2025 | -9.99 Mn |
| Mar 31, 2025 | -9.99 Mn |
| Dec 31, 2024 | -7.56 Mn |
| Dec 31, 2024 | -7.56 Mn |
| Sep 30, 2024 | -10.49 Mn |
| Sep 30, 2024 | -10.49 Mn |
| Jun 30, 2024 | -12.79 Mn |
| Jun 30, 2024 | -12.79 Mn |
| Mar 31, 2024 | 2.53 Mn |
| Mar 31, 2024 | 2.53 Mn |